Table 7
Therapeutic procedures for which no special radiation protection measures are required for transport and embalming of deceased patients, meeting the 300 μSv dose criterion per post-mortem procedure.
| Therapeutic procedure | Administered activity | How to proceed: body transport and embalming |
|---|---|---|
| phosphorus-32: polyglobulia treatment | 260 MBq | |
| strontium-89: bone metastases treatment | 150 MBq | |
| yttrium-90: Radiation synovectomy Non-Hodgkin lymphoma treatment Radioembolization of liver cancers with microspheres |
225 MBq 1.2 GBq 2 GBq (SIR-sphere®) 5 GBq (Therasphere®) |
No special radiation protection measures* (These post-mortem procedures can be carried out immediately) |
| iodine-131: benign thyroid diseases (below 700 MBq) | 700 MBq | |
| erbium-169: radiation synovectomy | 750 MBq | |
| rhenium-186: radiation synovectomy | 370 MBq | |
| radium-223: bone metastases treatment | 6 MBq | |
| actinium-225: metastatic prostate cancer | 15 MBq |
*In this study, external and internal contamination were not considered as funeral professionals routinely wear personal protective equipment (e.g., gloves) when handling the body, regardless of its radioactive status.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.